Abstract

Ingersoll Rand Inc. will report quarterly results on July 30, 2026 Post Market; consensus expects modest year-over-year growth in revenue and adjusted EPS, and investors will scrutinize pricing, mix, and portfolio additions for margin progress.

Market Forecast

Consensus for the current quarter points to revenue of 1.96 billion US dollars, up 6.04% year over year, adjusted EPS of 0.83, up 3.50% year over year, and EBIT of 453.12 million US dollars, up 2.41% year over year; no explicit consensus forecast has been indicated for gross profit margin or net profit margin. The core earnings engine remains anchored by the larger sales platform, supported by mix and pricing discipline against a last-quarter revenue base of 1.44 billion US dollars. The most promising segment is Precision and Science Technologies, which posted 402.70 million US dollars last quarter; YoY detail for that segment was not disclosed, but recent portfolio expansions are expected to support demand and profitability.

Last Quarter Review

In the previous quarter, Ingersoll Rand Inc. reported revenue of 1.85 billion US dollars, a gross profit margin of 42.90%, GAAP net profit attributable to the parent company of 192.00 million US dollars, a net profit margin of 10.40%, and adjusted EPS of 0.77, up 6.94% year over year; net profit declined 27.81% quarter on quarter. Adjusted EPS exceeded the company’s compiled consensus by 0.03, and reported revenue was 12.91 million US dollars above expectations. The main business mix was led by Industrial Technologies and Services at 1.44 billion US dollars and Precision and Science Technologies at 402.70 million US dollars; segment-level YoY detail was not disclosed, but the mix favored the larger platform.

Current Quarter Outlook

Industrial Technologies and Services

Industrial Technologies and Services, with a last-quarter revenue base of 1.44 billion US dollars, is positioned to drive the majority of the current quarter’s earnings cadence. Management’s operating strategy has emphasized mix curation, aftermarket penetration, and pricing discipline; those levers together typically support operating margin resiliency when topline growth moderates. In the consensus case, incremental revenue growth is forecast at 6.04%, and pricing has been a consistent contributor to year-over-year gains; that dynamic should also help buffer any input-cost variability and normalize incremental margin progression. The segment’s product breadth allows for commercial prioritization of higher-margin configurations and service packages, which often sustains gross margin even when volume growth is influenced by timing factors. With EBIT consensus implying 2.41% year-over-year growth and adjusted EPS expected to rise 3.50% year over year, the market is effectively embedding modest operating leverage; execution against service attachment, spare-parts mix, and lifecycle offerings will be key to translating revenue gains into EPS outperformance.

Precision and Science Technologies

Precision and Science Technologies contributed 402.70 million US dollars last quarter, and is the segment likely to show the best potential for sustained enhancement in profitability per unit of revenue. The company has announced recent portfolio additions in metering and dosing technologies, which are naturally aligned with higher-value applications and tend to carry attractive margin structures; this supports a constructive view on mix quality and pricing realization this quarter. Integration of new offerings can expand addressable opportunities within existing channels, enabling cross-selling and bundling that raise average selling prices and service attachment rates. While segment-level YoY data was not disclosed, ongoing commercial integration of the acquired technologies and an emphasis on oil-free compressor innovation through strategic partnerships are expected to provide incremental tailwinds to both revenue and margin. The near-term focus will be on demonstrating order conversion at favorable price points and confirming that engineering enhancements are translating into commercially differentiated performance that customers are willing to pay for. A measured ramp of new solutions, combined with execution on installation and service, typically yields steady margin accretion without requiring outsized volume growth.

Key Stock Price Drivers This Quarter

Three elements are likely to dominate share-price reaction when the company releases its results. First, revenue and EPS relative to consensus—1.96 billion US dollars and 0.83, respectively—will be the immediate yardsticks; a modest beat on EPS tends to be sufficient when paired with constructive commentary on mix and pricing. Second, margin commentary will matter at least as much as the headline EPS figure; investors have little explicit margin guidance, so concrete indications on gross margin drivers, net margin trajectory, and conversion of pricing into EBIT growth can be pivotal to the narrative. Third, updates on portfolio execution—particularly around the metering and dosing additions and the multiyear technology partnership in oil-free compression—will help investors refine expectations for the Precision and Science Technologies segment’s profitability path. Management’s tone on orders, the balance between original equipment and aftermarket, and the sustainability of pricing actions will influence how the market extrapolates today’s 6.04% revenue growth expectation into the back half of the year. If the company pairs in-line revenue with an EPS beat and confirms margin discipline is holding, the stock typically reacts constructively; conversely, if mix shifts or integration timing weigh on margin conversion, the market could recalibrate valuation multiples even if headline revenue meets expectations. Portfolio signals that show steady integration progress and a clear commercialization roadmap often provide enough visibility to offset small variances in quarterly volume.

Analyst Opinions

Bullish opinions dominate the recent six-month period, with Buy-rated views outweighing bearish calls by a ratio of 100% to 0% among captured rating notes; neutral stances exist but do not change the majority conclusion. Wells Fargo reaffirmed a Buy on Ingersoll Rand Inc., reflecting confidence in the company’s earnings drivers and mix-supported margin profile. Barclays maintained a Buy and cited a 100.00 US dollars price target, underscoring expectations that sustained revenue gains and disciplined pricing can underpin ongoing EPS growth. The broader analyst context remains constructive even as some institutions have trimmed targets in recent months; the maintained Buy ratings signal that the profit engine is intact and the strategic portfolio moves are seen as supportive of margin and cash generation. Market previews also point to consensus expectations of 1.96 billion US dollars in revenue and 0.83 in adjusted EPS for the quarter, a setup that conveys measured optimism with an emphasis on execution details at the margin line. The majority view anticipates that pricing, mix, and service intensity will continue to enhance profitability, while portfolio additions in metering and dosing and oil-free compression innovation provide incremental support to future quarters. In sum, the prevailing institutional stance is that the current quarter should deliver modest year-over-year improvements and keep the company’s earnings framework aligned with constructive expectations, with particular attention on confirming margin durability and the early returns from recently expanded offerings.